NuVasive had to raise its litigation royalty expense estimate for the year after a U.S. District Court set royalty rates for the company's CoRoent XL implants at 13.75 percent and MaXcess retractors at 8.25 percent.

San Diego, Calif.-based NuVasive reported increased gross profits for the 2013 first quarter at $120.4 million, up 4.9 percent from the same period last year.

MAKO Surgical has agreed to settle its patent infringement lawsuit against Stanmore Implants Worldwide and will acquire some of Stanmore's assets.

TranS1 medical device company posted a net loss of $12 million for the fourth quarter of 2012, due in part to increased operating expenses from a government settlement.

The Wilmington, N.C.-based medical device company TranS1 has reached a $6 million agreement with the US Department of Justice to settle a federal investigation.

The following 12 settlements involved alleged False Claims Act violations, exceeded $1 million and were reached by hospitals and/or health systems within the past year. Settlements are arranged in descending dollar value.

Orthofix's investigation into its bone growth stimulation business has concluded, and the company will pay $43 million to fully resolve matters, both criminal and civil.

Biomet has reached a deferred prosecution agreement with the U.S. Department of Justice and a consent to final judgment with the U.S. Securities and Exchange Commission related to a Foreign Corrupt Practices Act investigation.

Globus Medical's Chairman and CEO David Paul announced reaching a settlement with the Food and Drug Administration to result complaints alleging the company violated the Food, Drug and Cosmetic Act with its former product, NuBone.

Sports medicine device company ArthroCare recently reached an agreement in principle to settle pending private securities class action suits against the company and two former officers, according to an ArthroCare news release.